Frontiers in Immunology (Jul 2024)

Monocyte/macrophage-mediated venous thrombus resolution

  • Meng-Jiao Lu,
  • Meng-Jiao Lu,
  • Jia-Qi Zhang,
  • Zhou-Yu Nie,
  • Tian-Hua Yan,
  • Yong-Bing Cao,
  • Li-Chao Zhang,
  • Ling Li

DOI
https://doi.org/10.3389/fimmu.2024.1429523
Journal volume & issue
Vol. 15

Abstract

Read online

Venous thromboembolism (VTE) poses a notable risk of morbidity and mortality. The natural resolution of the venous thrombus might be a potential alternative treatment strategy for VTE. Monocytes/macrophages merge as pivotal cell types in the gradual resolution of the thrombus. In this review, the vital role of macrophages in inducing inflammatory response, augmenting neovascularization, and facilitating the degradation of fibrin and collagen during thrombus resolution was described. The two phenotypes of macrophages involved in thrombus resolution and their dual functions were discussed. Macrophages expressing various factors, including cytokines and their receptors, adhesion molecules, chemokine receptors, vascular endothelial growth factor receptors, profibrinolytic- or antifibrinolytic-related enzymes, and other elements, are explored for their potential to promote or attenuate thrombus resolution. Furthermore, this review provides a comprehensive summary of new and promising therapeutic candidate drugs associated with monocytes/macrophages that have been demonstrated to promote or impair thrombus resolution. However, further clinical trials are essential to validate their efficacy in VTE therapy.

Keywords